Level of RUNX1 activity is critical for leukemic predisposition but not for thrombocytopeniaIléana Antony‐Debré, Hana Raslová|Blood|2014Cited by 96
MYH10 protein expression in platelets as a biomarker of RUNX1 and FLI1 alterationsIléana Antony‐Debré, Hana Raslová|Blood|2012Cited by 79
The Folate Cycle Enzyme MTHFR Is a Critical Regulator of Cell Response to MYC-Targeting TherapiesAngela Su, Alexandre Puissant, Frank Ling et al.|Cancer Discovery|2020Cited by 26
The Folate Cycle Enzyme MTHFR Is a Critical Regulator of Cell Response to MYC-Targeting TherapiesAngela Su, Alexandre Puissant, Bryann Pardieu et al.|Blood|2019Cited by 5
Figure S6 from The Folate Cycle Enzyme MTHFR Is a Critical Regulator of Cell Response to MYC-Targeting TherapiesAngela Su, Alexandre Puissant, Frank W. Ling et al.|Unknown|2023Cited by 0